Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers.
Animals
Biomarkers, Tumor
/ blood
Cell Line
Extracellular Vesicles
/ metabolism
HSC70 Heat-Shock Proteins
/ metabolism
Humans
Machine Learning
Mice
Mice, Inbred C57BL
Microfilament Proteins
/ metabolism
Neoplasms
/ diagnosis
Proteome
/ analysis
Proteomics
/ methods
Sensitivity and Specificity
Tetraspanin 29
/ metabolism
rap GTP-Binding Proteins
/ metabolism
biomarkers
cancer
cancer of unknown primary origin
damage-associated molecular patterns
early cancer detection
exomeres
exosomes
extracellular vesicles and particles
liquid biopsy
proteomics
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
20 08 2020
20 08 2020
Historique:
received:
06
01
2020
revised:
23
04
2020
accepted:
09
07
2020
pubmed:
17
8
2020
medline:
2
4
2021
entrez:
16
8
2020
Statut:
ppublish
Résumé
There is an unmet clinical need for improved tissue and liquid biopsy tools for cancer detection. We investigated the proteomic profile of extracellular vesicles and particles (EVPs) in 426 human samples from tissue explants (TEs), plasma, and other bodily fluids. Among traditional exosome markers, CD9, HSPA8, ALIX, and HSP90AB1 represent pan-EVP markers, while ACTB, MSN, and RAP1B are novel pan-EVP markers. To confirm that EVPs are ideal diagnostic tools, we analyzed proteomes of TE- (n = 151) and plasma-derived (n = 120) EVPs. Comparison of TE EVPs identified proteins (e.g., VCAN, TNC, and THBS2) that distinguish tumors from normal tissues with 90% sensitivity/94% specificity. Machine-learning classification of plasma-derived EVP cargo, including immunoglobulins, revealed 95% sensitivity/90% specificity in detecting cancer. Finally, we defined a panel of tumor-type-specific EVP proteins in TEs and plasma, which can classify tumors of unknown primary origin. Thus, EVP proteins can serve as reliable biomarkers for cancer detection and determining cancer type.
Identifiants
pubmed: 32795414
pii: S0092-8674(20)30874-6
doi: 10.1016/j.cell.2020.07.009
pmc: PMC7522766
mid: NIHMS1612511
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
HSC70 Heat-Shock Proteins
0
HSPA8 protein, human
0
Microfilament Proteins
0
Proteome
0
Tetraspanin 29
0
moesin
144131-77-1
RAP1B protein, human
EC 3.6.1.-
rap GTP-Binding Proteins
EC 3.6.5.2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1044-1061.e18Subventions
Organisme : NCI NIH HHS
ID : U54 CA163120
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA163117
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218513
Pays : United States
Organisme : NIOSH CDC HHS
ID : U19 OH009077
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI144301
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002384
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA210240
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA064786
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207983
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA127297
Pays : United States
Organisme : NCI NIH HHS
ID : R50 CA211462
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR027699
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA169416
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA169538
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA224175
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA217169
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA232093
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests D.L., A.H., H.S.K., and L.B. have filed a U.S. patent application related to this work.
Références
Blood. 2002 Aug 1;100(3):897-904
pubmed: 12130500
Proteomics. 2017 Dec;17(23-24):
pubmed: 29115712
J Cell Sci. 1994 Jun;107 ( Pt 6):1661-70
pubmed: 7962206
N Engl J Med. 2014 Aug 21;371(8):757-65
pubmed: 25140961
World J Gastroenterol. 2016 Mar 7;22(9):2678-700
pubmed: 26973408
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Oncogene. 2016 Nov 17;35(46):5931-5941
pubmed: 27086930
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
Cells. 2018 Oct 05;7(10):
pubmed: 30301152
Trends Cell Biol. 2017 Mar;27(3):172-188
pubmed: 27979573
Nat Cell Biol. 2008 Dec;10(12):1470-6
pubmed: 19011622
Cell Rep. 2019 Apr 16;27(3):940-954.e6
pubmed: 30956133
Proteomics. 2013 May;13(10-11):1672-86
pubmed: 23585443
Nature. 2005 Jul 28;436(7050):518-24
pubmed: 16049480
J Vis Exp. 2013 Jan 03;(71):
pubmed: 23328888
Mass Spectrom Rev. 2015 Jul-Aug;34(4):474-90
pubmed: 24421117
J Transl Med. 2012 Jan 24;10:12
pubmed: 22272606
Electrophoresis. 1999 Dec;20(18):3551-67
pubmed: 10612281
Nature. 2020 Jan;577(7791):549-555
pubmed: 31942075
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Proteomics. 2009 Nov;9(21):4997-5000
pubmed: 19810033
Cancer Cell. 2005 May;7(5):469-83
pubmed: 15894267
Cancer Res. 2008 Jun 15;68(12):4500-5
pubmed: 18559492
J Biol Chem. 1987 Jul 5;262(19):9412-20
pubmed: 3597417
Int Immunol. 2005 Jul;17(7):879-87
pubmed: 15908444
Nat Protoc. 2019 Apr;14(4):1027-1053
pubmed: 30833697
Nat Cell Biol. 2018 Mar;20(3):332-343
pubmed: 29459780
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Mol Biol Cell. 2016 Nov 1;27(21):3305-3316
pubmed: 27605702
PLoS Biol. 2012;10(12):e1001450
pubmed: 23271954
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Cell Res. 2014 Jun;24(6):766-9
pubmed: 24710597
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180
pubmed: 28270605
J Immunol Methods. 2002 Dec 15;270(2):211-26
pubmed: 12379326
Cancer Cell. 2005 Sep;8(3):185-95
pubmed: 16169464
Eur J Cell Biol. 1999 Nov;78(11):802-12
pubmed: 10604657
Cancer Immun. 2010 Oct 20;10:9
pubmed: 20957980
Cancer Cell. 2016 Dec 12;30(6):836-848
pubmed: 27960084
Ann Oncol. 2018 Jan 1;29(1):223-229
pubmed: 29045505
Oncotarget. 2016 Dec 27;7(52):86999-87015
pubmed: 27894104
Cancer Cell. 2002 Sep;2(3):205-16
pubmed: 12242153
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Semin Cancer Biol. 2018 Aug;51:116-128
pubmed: 28919484
Bioinformatics. 2015 Mar 15;31(6):933-9
pubmed: 25388151
Nature. 2009 Jun 18;459(7249):1005-9
pubmed: 19421193
Nat Cell Biol. 2019 Nov;21(11):1403-1412
pubmed: 31685984
Cancer Cell. 2003 Jun;3(6):537-49
pubmed: 12842083
Science. 1999 Oct 15;286(5439):531-7
pubmed: 10521349
Cell Mol Bioeng. 2016 Dec;9(4):509-529
pubmed: 28392840
J Bone Miner Res. 2001 Aug;16(8):1486-95
pubmed: 11499871
N Engl J Med. 2015 Jun 11;372(24):2359-62
pubmed: 26061842
J Cell Physiol. 2012 Jul;227(7):2953-64
pubmed: 21959869
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394